Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial

BACKGROUND: High oxidative stress and chronic inflammation can contribute to the pathogenesis of coronary artery disease (CAD). Coenzyme Q10 is an endogenous lipid-soluble antioxidant. Statins therapy can reduce the biosynthesis of coenzyme Q10. The purpose of this study was to investigate the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bor-Jen, Tseng, Yu-Fen, Yen, Chi-Hua, Lin, Ping-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176102/
https://www.ncbi.nlm.nih.gov/pubmed/24192015
http://dx.doi.org/10.1186/1475-2891-12-142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176102/
https://www.ncbi.nlm.nih.gov/pubmed/24192015
http://dx.doi.org/10.1186/1475-2891-12-142

Ejemplares similares